カテゴリー： Market Monitor Global, 世界, 医療/バイオ

関節炎処方薬の世界市場見通し2023年-2029年

◆英語タイトル：Prescription Arthritis Medications Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8592 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：71 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Prescription Arthritis Medications Market 調査レポートは次の情報を含め、グローバルにおけるの関節炎処方薬市場規模と予測を収録しています。・世界の関節炎処方薬市場：売上、2018年-2023年、2024年-2029年
・世界の関節炎処方薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の関節炎処方薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口投与」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

関節炎処方薬のグローバル主要企業は、Abbott、 Amgen、 Boehringer Ingelheim、 Horizon Pharma、 Novartis、 Pfizer、 Regeneronなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、関節炎処方薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の関節炎処方薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の関節炎処方薬市場：タイプ別市場シェア、2022年
・経口投与、局所投与

世界の関節炎処方薬市場：用途別、2018年-2023年、2024年-2029年
世界の関節炎処方薬市場：用途別市場シェア、2022年
・病院薬局、オンライン薬局、小売薬局

世界の関節炎処方薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の関節炎処方薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における関節炎処方薬のグローバル売上、2018年-2023年
・主要企業における関節炎処方薬のグローバル売上シェア、2022年
・主要企業における関節炎処方薬のグローバル販売量、2018年-2023年
・主要企業における関節炎処方薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbott、 Amgen、 Boehringer Ingelheim、 Horizon Pharma、 Novartis、 Pfizer、 Regeneron

*************************************************************

・調査・分析レポートの概要
関節炎処方薬市場の定義
市場セグメント
世界の関節炎処方薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の関節炎処方薬市場規模
世界の関節炎処方薬市場規模：2022年 VS 2029年
世界の関節炎処方薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの関節炎処方薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の関節炎処方薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口投与、局所投与
関節炎処方薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、オンライン薬局、小売薬局
関節炎処方薬の用途別グローバル売上・予測

・地域別市場分析
地域別関節炎処方薬市場規模 2022年と2029年
地域別関節炎処方薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott、 Amgen、 Boehringer Ingelheim、 Horizon Pharma、 Novartis、 Pfizer、 Regeneron
...

Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.
This report aims to provide a comprehensive presentation of the global market for Prescription Arthritis Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Arthritis Medications. This report contains market size and forecasts of Prescription Arthritis Medications in global, including the following market information:
Global Prescription Arthritis Medications Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prescription Arthritis Medications Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prescription Arthritis Medications companies in 2022 (%)
The global Prescription Arthritis Medications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prescription Arthritis Medications include Abbott, Amgen, Boehringer Ingelheim, Horizon Pharma, Novartis, Pfizer and Regeneron, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Arthritis Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Arthritis Medications Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Arthritis Medications Market Segment Percentages, by Type, 2022 (%)
Oral
Topical
Global Prescription Arthritis Medications Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Arthritis Medications Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Prescription Arthritis Medications Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Arthritis Medications Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Arthritis Medications revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prescription Arthritis Medications revenues share in global market, 2022 (%)
Key companies Prescription Arthritis Medications sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prescription Arthritis Medications sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Amgen
Boehringer Ingelheim
Horizon Pharma
Novartis
Pfizer
Regeneron
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prescription Arthritis Medications, market overview.
Chapter 2: Global Prescription Arthritis Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Prescription Arthritis Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Arthritis Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prescription Arthritis Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Prescription Arthritis Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Arthritis Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Arthritis Medications Overall Market Size
2.1 Global Prescription Arthritis Medications Market Size: 2022 VS 2029
2.2 Global Prescription Arthritis Medications Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prescription Arthritis Medications Sales: 2018-2029
3 Company Landscape
3.1 Top Prescription Arthritis Medications Players in Global Market
3.2 Top Global Prescription Arthritis Medications Companies Ranked by Revenue
3.3 Global Prescription Arthritis Medications Revenue by Companies
3.4 Global Prescription Arthritis Medications Sales by Companies
3.5 Global Prescription Arthritis Medications Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prescription Arthritis Medications Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prescription Arthritis Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Arthritis Medications Players in Global Market
3.8.1 List of Global Tier 1 Prescription Arthritis Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Arthritis Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Prescription Arthritis Medications Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Topical
4.2 By Type – Global Prescription Arthritis Medications Revenue & Forecasts
4.2.1 By Type – Global Prescription Arthritis Medications Revenue, 2018-2023
4.2.2 By Type – Global Prescription Arthritis Medications Revenue, 2024-2029
4.2.3 By Type – Global Prescription Arthritis Medications Revenue Market Share, 2018-2029
4.3 By Type – Global Prescription Arthritis Medications Sales & Forecasts
4.3.1 By Type – Global Prescription Arthritis Medications Sales, 2018-2023
4.3.2 By Type – Global Prescription Arthritis Medications Sales, 2024-2029
4.3.3 By Type – Global Prescription Arthritis Medications Sales Market Share, 2018-2029
4.4 By Type – Global Prescription Arthritis Medications Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prescription Arthritis Medications Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application – Global Prescription Arthritis Medications Revenue & Forecasts
5.2.1 By Application – Global Prescription Arthritis Medications Revenue, 2018-2023
5.2.2 By Application – Global Prescription Arthritis Medications Revenue, 2024-2029
5.2.3 By Application – Global Prescription Arthritis Medications Revenue Market Share, 2018-2029
5.3 By Application – Global Prescription Arthritis Medications Sales & Forecasts
5.3.1 By Application – Global Prescription Arthritis Medications Sales, 2018-2023
5.3.2 By Application – Global Prescription Arthritis Medications Sales, 2024-2029
5.3.3 By Application – Global Prescription Arthritis Medications Sales Market Share, 2018-2029
5.4 By Application – Global Prescription Arthritis Medications Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Prescription Arthritis Medications Market Size, 2022 & 2029
6.2 By Region – Global Prescription Arthritis Medications Revenue & Forecasts
6.2.1 By Region – Global Prescription Arthritis Medications Revenue, 2018-2023
6.2.2 By Region – Global Prescription Arthritis Medications Revenue, 2024-2029
6.2.3 By Region – Global Prescription Arthritis Medications Revenue Market Share, 2018-2029
6.3 By Region – Global Prescription Arthritis Medications Sales & Forecasts
6.3.1 By Region – Global Prescription Arthritis Medications Sales, 2018-2023
6.3.2 By Region – Global Prescription Arthritis Medications Sales, 2024-2029
6.3.3 By Region – Global Prescription Arthritis Medications Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Prescription Arthritis Medications Revenue, 2018-2029
6.4.2 By Country – North America Prescription Arthritis Medications Sales, 2018-2029
6.4.3 US Prescription Arthritis Medications Market Size, 2018-2029
6.4.4 Canada Prescription Arthritis Medications Market Size, 2018-2029
6.4.5 Mexico Prescription Arthritis Medications Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Prescription Arthritis Medications Revenue, 2018-2029
6.5.2 By Country – Europe Prescription Arthritis Medications Sales, 2018-2029
6.5.3 Germany Prescription Arthritis Medications Market Size, 2018-2029
6.5.4 France Prescription Arthritis Medications Market Size, 2018-2029
6.5.5 U.K. Prescription Arthritis Medications Market Size, 2018-2029
6.5.6 Italy Prescription Arthritis Medications Market Size, 2018-2029
6.5.7 Russia Prescription Arthritis Medications Market Size, 2018-2029
6.5.8 Nordic Countries Prescription Arthritis Medications Market Size, 2018-2029
6.5.9 Benelux Prescription Arthritis Medications Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Prescription Arthritis Medications Revenue, 2018-2029
6.6.2 By Region – Asia Prescription Arthritis Medications Sales, 2018-2029
6.6.3 China Prescription Arthritis Medications Market Size, 2018-2029
6.6.4 Japan Prescription Arthritis Medications Market Size, 2018-2029
6.6.5 South Korea Prescription Arthritis Medications Market Size, 2018-2029
6.6.6 Southeast Asia Prescription Arthritis Medications Market Size, 2018-2029
6.6.7 India Prescription Arthritis Medications Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Prescription Arthritis Medications Revenue, 2018-2029
6.7.2 By Country – South America Prescription Arthritis Medications Sales, 2018-2029
6.7.3 Brazil Prescription Arthritis Medications Market Size, 2018-2029
6.7.4 Argentina Prescription Arthritis Medications Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Prescription Arthritis Medications Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Prescription Arthritis Medications Sales, 2018-2029
6.8.3 Turkey Prescription Arthritis Medications Market Size, 2018-2029
6.8.4 Israel Prescription Arthritis Medications Market Size, 2018-2029
6.8.5 Saudi Arabia Prescription Arthritis Medications Market Size, 2018-2029
6.8.6 UAE Prescription Arthritis Medications Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Prescription Arthritis Medications Major Product Offerings
7.1.4 Abbott Prescription Arthritis Medications Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Prescription Arthritis Medications Major Product Offerings
7.2.4 Amgen Prescription Arthritis Medications Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Prescription Arthritis Medications Major Product Offerings
7.3.4 Boehringer Ingelheim Prescription Arthritis Medications Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Horizon Pharma
7.4.1 Horizon Pharma Company Summary
7.4.2 Horizon Pharma Business Overview
7.4.3 Horizon Pharma Prescription Arthritis Medications Major Product Offerings
7.4.4 Horizon Pharma Prescription Arthritis Medications Sales and Revenue in Global (2018-2023)
7.4.5 Horizon Pharma Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Prescription Arthritis Medications Major Product Offerings
7.5.4 Novartis Prescription Arthritis Medications Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Prescription Arthritis Medications Major Product Offerings
7.6.4 Pfizer Prescription Arthritis Medications Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Regeneron
7.7.1 Regeneron Company Summary
7.7.2 Regeneron Business Overview
7.7.3 Regeneron Prescription Arthritis Medications Major Product Offerings
7.7.4 Regeneron Prescription Arthritis Medications Sales and Revenue in Global (2018-2023)
7.7.5 Regeneron Key News & Latest Developments
8 Global Prescription Arthritis Medications Production Capacity, Analysis
8.1 Global Prescription Arthritis Medications Production Capacity, 2018-2029
8.2 Prescription Arthritis Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Arthritis Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Arthritis Medications Supply Chain Analysis
10.1 Prescription Arthritis Medications Industry Value Chain
10.2 Prescription Arthritis Medications Upstream Market
10.3 Prescription Arthritis Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Arthritis Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Prescription Arthritis Medications in Global Market
Table 2. Top Prescription Arthritis Medications Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prescription Arthritis Medications Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prescription Arthritis Medications Revenue Share by Companies, 2018-2023
Table 5. Global Prescription Arthritis Medications Sales by Companies, (K Units), 2018-2023
Table 6. Global Prescription Arthritis Medications Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prescription Arthritis Medications Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Prescription Arthritis Medications Product Type
Table 9. List of Global Tier 1 Prescription Arthritis Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prescription Arthritis Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Prescription Arthritis Medications Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Prescription Arthritis Medications Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prescription Arthritis Medications Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Prescription Arthritis Medications Sales (K Units), 2018-2023
Table 15. By Type - Global Prescription Arthritis Medications Sales (K Units), 2024-2029
Table 16. By Application – Global Prescription Arthritis Medications Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Prescription Arthritis Medications Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prescription Arthritis Medications Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Prescription Arthritis Medications Sales (K Units), 2018-2023
Table 20. By Application - Global Prescription Arthritis Medications Sales (K Units), 2024-2029
Table 21. By Region – Global Prescription Arthritis Medications Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Prescription Arthritis Medications Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prescription Arthritis Medications Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Prescription Arthritis Medications Sales (K Units), 2018-2023
Table 25. By Region - Global Prescription Arthritis Medications Sales (K Units), 2024-2029
Table 26. By Country - North America Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prescription Arthritis Medications Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Prescription Arthritis Medications Sales, (K Units), 2018-2023
Table 29. By Country - North America Prescription Arthritis Medications Sales, (K Units), 2024-2029
Table 30. By Country - Europe Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prescription Arthritis Medications Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Prescription Arthritis Medications Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prescription Arthritis Medications Sales, (K Units), 2024-2029
Table 34. By Region - Asia Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prescription Arthritis Medications Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Prescription Arthritis Medications Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prescription Arthritis Medications Sales, (K Units), 2024-2029
Table 38. By Country - South America Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prescription Arthritis Medications Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Prescription Arthritis Medications Sales, (K Units), 2018-2023
Table 41. By Country - South America Prescription Arthritis Medications Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prescription Arthritis Medications Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Prescription Arthritis Medications Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prescription Arthritis Medications Sales, (K Units), 2024-2029
Table 46. Abbott Company Summary
Table 47. Abbott Prescription Arthritis Medications Product Offerings
Table 48. Abbott Prescription Arthritis Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Prescription Arthritis Medications Product Offerings
Table 52. Amgen Prescription Arthritis Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Prescription Arthritis Medications Product Offerings
Table 56. Boehringer Ingelheim Prescription Arthritis Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Horizon Pharma Company Summary
Table 59. Horizon Pharma Prescription Arthritis Medications Product Offerings
Table 60. Horizon Pharma Prescription Arthritis Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Horizon Pharma Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Prescription Arthritis Medications Product Offerings
Table 64. Novartis Prescription Arthritis Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Prescription Arthritis Medications Product Offerings
Table 68. Pfizer Prescription Arthritis Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Regeneron Company Summary
Table 71. Regeneron Prescription Arthritis Medications Product Offerings
Table 72. Regeneron Prescription Arthritis Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Regeneron Key News & Latest Developments
Table 74. Prescription Arthritis Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Prescription Arthritis Medications Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Prescription Arthritis Medications Production by Region, 2018-2023 (K Units)
Table 77. Global Prescription Arthritis Medications Production by Region, 2024-2029 (K Units)
Table 78. Prescription Arthritis Medications Market Opportunities & Trends in Global Market
Table 79. Prescription Arthritis Medications Market Drivers in Global Market
Table 80. Prescription Arthritis Medications Market Restraints in Global Market
Table 81. Prescription Arthritis Medications Raw Materials
Table 82. Prescription Arthritis Medications Raw Materials Suppliers in Global Market
Table 83. Typical Prescription Arthritis Medications Downstream
Table 84. Prescription Arthritis Medications Downstream Clients in Global Market
Table 85. Prescription Arthritis Medications Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prescription Arthritis Medications Segment by Type in 2022
Figure 2. Prescription Arthritis Medications Segment by Application in 2022
Figure 3. Global Prescription Arthritis Medications Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prescription Arthritis Medications Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prescription Arthritis Medications Revenue, 2018-2029 (US$, Mn)
Figure 7. Prescription Arthritis Medications Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prescription Arthritis Medications Revenue in 2022
Figure 9. By Type - Global Prescription Arthritis Medications Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Prescription Arthritis Medications Revenue Market Share, 2018-2029
Figure 11. By Type - Global Prescription Arthritis Medications Sales Market Share, 2018-2029
Figure 12. By Type - Global Prescription Arthritis Medications Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Prescription Arthritis Medications Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Prescription Arthritis Medications Revenue Market Share, 2018-2029
Figure 15. By Application - Global Prescription Arthritis Medications Sales Market Share, 2018-2029
Figure 16. By Application - Global Prescription Arthritis Medications Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Prescription Arthritis Medications Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Prescription Arthritis Medications Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Prescription Arthritis Medications Revenue Market Share, 2018-2029
Figure 20. By Region - Global Prescription Arthritis Medications Sales Market Share, 2018-2029
Figure 21. By Country - North America Prescription Arthritis Medications Revenue Market Share, 2018-2029
Figure 22. By Country - North America Prescription Arthritis Medications Sales Market Share, 2018-2029
Figure 23. US Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Prescription Arthritis Medications Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Prescription Arthritis Medications Sales Market Share, 2018-2029
Figure 28. Germany Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 29. France Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Prescription Arthritis Medications Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Prescription Arthritis Medications Sales Market Share, 2018-2029
Figure 37. China Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 41. India Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Prescription Arthritis Medications Revenue Market Share, 2018-2029
Figure 43. By Country - South America Prescription Arthritis Medications Sales Market Share, 2018-2029
Figure 44. Brazil Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Prescription Arthritis Medications Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Prescription Arthritis Medications Sales Market Share, 2018-2029
Figure 48. Turkey Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Prescription Arthritis Medications Revenue, (US$, Mn), 2018-2029
Figure 52. Global Prescription Arthritis Medications Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Prescription Arthritis Medications by Region, 2022 VS 2029
Figure 54. Prescription Arthritis Medications Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 関節炎処方薬の世界市場見通し2023年-2029年(Prescription Arthritis Medications Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

関節炎処方薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp